Experts at the University are studying an illness known as HAPE (high altitude pulmonary oedema), which causes fluid to build up in the lungs can and can occur from as low as 2,500 metres, affecting people of all age groups and fitness levels.
Non-medicinal interventions are highly effective in preventing the behavioral and academic problems associated with Attention Deficit Hyperactivity Disorder (ADHD), according to a five-year study led by researchers at Lehigh University?s College of Education.
Groundbreaking research from the University of Melbourne has shed new light on why long term drug users find it hard to say no, despite dire consequences to their health.
Reclast (zoledronic acid) Injection — the first and only once-yearly medicine for postmenopausal osteoporosis — has been approved by the US Food and Drug Administration FDA.
If you think the big cities of Toronto and Montreal have the highest rate of alcohol and drug use problems, think again. A new study entitled ?Geographical Variation in the Prevalence of Problematic Substance Use in Canada? authored by three researchers from the Centre for Addiction and Mental Health (CAMH) discovered that Ontario and Quebec had markedly lower concentrations of people with alcohol and drug problems.
A coalition of physicians representing a wide range of medical specialties has issued a call to action to improve the treatment of stroke. The group, which includes nationally recognized leaders in neurology, neuroradiology, neurosurgery, vascular surgery and cardiology, was drawn together by the Society for Cardiovascular Angiography and Interventions to address one of the most pressing medical needs in this country — the rapid treatment of stroke using catheter-based techniques.
The University of Rochester Medical Center announced the opening of the Aab Cardiovascular Research Institute (CVRI) in the Town of Henrietta. More than 100 scientists, students and technicians, currently housed across the Medical Center’s campus, will be brought together under one roof.
A change to the Pharmaceutical Benefits scheme (PBS) from 1 October 2007 will provide subsidised access to adults and children of Remicade? (infliximab) for the treatment of Crohn?s disease.
Statistics released this week by the Private Health Insurance Administration Council show that private health hospital insurance has increased for the eighth consecutive quarter ? with more than 76,000 additional people covered in the June quarter.
Johns Hopkins scientists have found yet another reason why you should listen to your mother when she tells you to eat your vegetables. Sulforaphane, a chemical present at high levels in a precursor form in broccoli and related veggies (cauliflower, Brussels sprouts, etc.), helps prevent the severe blistering and skin breakage brought on by the rare and potentially fatal genetic disease epidermolysis bullosa simplex (EBS).